Page last updated: 2024-11-01

nitroglycerin and Glycogen Storage Disease Type V

nitroglycerin has been researched along with Glycogen Storage Disease Type V in 1 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toussaint, M1
Duboc, D1
Renault, G1
Guerin, F1
Degeorges, M1

Other Studies

1 other study available for nitroglycerin and Glycogen Storage Disease Type V

ArticleYear
[Laser fluorimetry of NADH].
    Archives des maladies du coeur et des vaisseaux, 1988, Volume: 81 Spec No

    Topics: Animals; Coronary Angiography; Coronary Disease; Energy Metabolism; Fluorometry; Glycogen Storage Di

1988